Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30044536HIVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS30021386HIVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS30044537HIVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS30044538HIVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS20004431HPVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS20007824HPVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS20005056HPVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS20015904HPVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS20015848HPVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TVIS20016610HPVENSG00000108423.16protein_codingTUBD1NoNo51174Q9UJT1
TCGA Plot Options
Drug Information
GeneTUBD1
DrugBank IDDB00570
Drug NameVinblastine
Target IDBE0003711
UniProt IDQ9UJT1
Regulation Typebinder
PubMed IDs18220533; 1818332; 9664292; 15579115; 14619954
CitationsJordan MA, Kamath K: How do microtubule-targeted drugs work? An overview. Curr Cancer Drug Targets. 2007 Dec;7(8):730-42.@@Correia JJ: Effects of antimitotic agents on tubulin-nucleotide interactions. Pharmacol Ther. 1991 Nov;52(2):127-47.@@Jordan A, Hadfield JA, Lawrence NJ, McGown AT: Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev. 1998 Jul;18(4):259-96.@@Islam MN, Iskander MN: Microtubulin binding sites as target for developing anticancer agents. Mini Rev Med Chem. 2004 Dec;4(10):1077-104.@@Gupta S, Bhattacharyya B: Antimicrotubular drugs binding to vinca domain of tubulin. Mol Cell Biochem. 2003 Nov;253(1-2):41-7.
GroupsApproved
Direct ClassificationVinca alkaloids
SMILES[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=C2C=CC=C1)C(=O)OC
PathwaysVinblastine Action Pathway
PharmGKBPA451877
ChEMBLCHEMBL159